U.S. Commercial Services Stock News

TPG Inc. recently reported third quarter 2025 results, showing revenue of US$1.22 billion and net income of US$67.14 million, both reflecting substantial increases from the same period a year earlier. Management credited these improvements to strong fundraising momentum and record capital deployment, which management believes provide increased margin stability and sustain performance-related earnings. We'll examine how TPG's significant revenue and net income growth this quarter may shift...

Wondering if Palantir stock is a hidden gem or if the story has already played out? Let's dig into whether the current price really stacks up to the company's fundamentals. After a remarkable 131.4% gain year-to-date and a 164.6% return over the past year, Palantir has certainly caught the market’s attention, even with a brief pullback of 3.1% in the last month. Much of this excitement follows Palantir’s recent expansion into several high-profile government contracts and its steady push into...

Burlington Stores (BURL) shares have shown slight movement lately, prompting some investors to revisit the retailer’s performance. The company’s stock has experienced mixed returns over the past month and continues to draw attention in the retail sector. See our latest analysis for Burlington Stores. While Burlington Stores’ share price return has been fairly muted recently, the bigger story is that momentum has slowed after a strong multi-year run. The company’s total shareholder return of...

Eve Holding (NYSE:EVEX) has signed a framework agreement with Bahrain’s Ministry of Transportation and Telecommunications, aiming to fast-track sustainable air mobility across the Middle East. The initiative paves the way for eVTOL operations and international expansion. See our latest analysis for Eve Holding. While Eve Holding’s agreement with Bahrain marks an exciting step towards international expansion, the company’s share price has faced significant pressure recently, with a 22.6%...

BellRing Brands (BRBR) shares have been on a slide this month, losing over 21% in the past month and nearly 30% over the past 3 months. The stock’s recent journey has caught the attention of investors searching for value opportunities. See our latest analysis for BellRing Brands. Zooming out, BellRing Brands has seen momentum fade, with a year-to-date share price return of -63.86% and a 1-year total shareholder return of -62.60%, even though it has still posted gains over the past three and...

Teladoc Health (TDOC) shares have lost around 23% over the past month, following a steady string of losses in the digital health sector. Investors are now watching for signs of stabilization or a shift in market sentiment. See our latest analysis for Teladoc Health. Teladoc Health’s share price has suffered a sharp 1-month drop of 22.6%, adding to a challenging year where its total shareholder return is down nearly 25% and momentum continues to fade. The latest decline reflects cautious...

Peloton Interactive and the Formula 1 Las Vegas Grand Prix recently announced a collaboration to deliver exclusive fitness classes and experiences during the Grand Prix weekend, including onsite and virtual programming such as trackside workouts and scenic rides around the Las Vegas Strip Circuit. This partnership not only aligns Peloton with a global sports event but also extends the reach of its new Cross Training Series and leverages high-impact media exposure in a location known for its...

Dime Community Bancshares (DCOM) recently filed a universal shelf registration, which allows it to issue debt, equity, and other financial instruments. This move could set the stage for future financing opportunities and may influence how investors view the stock. See our latest analysis for Dime Community Bancshares. Over the past year, Dime Community Bancshares’ share price has trended lower, down 10.5% year-to-date and delivering a -16.5% total shareholder return. This comes despite the...

UroGen Pharma (URGN) has caught the attention of investors recently, with shares showing significant momentum over the past month. The company’s stock price has surged 37%, far outpacing broader industry trends and prompting fresh interest in its underlying story. See our latest analysis for UroGen Pharma. Zooming out, UroGen Pharma’s 37% share price rise over the past month has pulled it well ahead of the sector, building on a stellar year-to-date share price return of 122%. That momentum is...

Acadian Asset Management (NYSE:AAMI) just released its third quarter earnings, revealing strong revenue growth for both the quarter and year-to-date periods. However, despite higher revenues, quarterly net income and earnings per share ticked down slightly. See our latest analysis for Acadian Asset Management. Strong revenue growth has certainly put Acadian Asset Management on investors’ radar, but the market’s response has reflected both optimism and caution; while the stock has soared with...

Praxis Precision Medicines recently announced it has reached alignment with the FDA on using interim results from the EMBOLD study as a potential basis for early NDA submission for relutrigine in rare pediatric epilepsies, pending positive data in late 2025. This regulatory agreement marks an important step toward accelerating access to a potential first approved treatment for ultra-rare, life-threatening epileptic encephalopathies that currently have no FDA-approved options. We'll explore...

On November 6, 2025, Bread Financial Holdings closed a US$500 million offering of 6.750% Senior Notes due 2031, supported by guarantees from its key domestic subsidiaries and structured with multiple redemption options and terms balancing creditor and company interests. This move reflects Bread Financial’s focus on actively managing its capital structure and funding flexibility to support future growth and operational needs. We’ll examine how this expanded funding base could reinforce Bread...

CG Oncology (CGON) shares have been capturing attention lately, particularly given the swings seen over the past month. Investors seem curious about how these changes could reshape the company’s near-term prospects in the biotech sector. See our latest analysis for CG Oncology. After a strong 90-day share price return of 59.57% and a year-to-date climb of 41.56%, CG Oncology’s recent moves suggest that investor momentum is gathering pace. The 1-year total shareholder return of 24.67%...

DENTSPLY SIRONA reported a US$263 million noncash impairment charge related to goodwill and intangible assets for the third quarter of 2025, revised its full-year sales guidance downward, and announced the departure of its Chief Financial Officer. The impairment was primarily attributed to tariffs and reduced projected equipment, implant, and prosthetic volumes in the U.S., signaling potential challenges in some of the company’s core markets. We’ll examine how the impairment charge and...

F&G Annuities & Life announced a 14% increase in its quarterly common dividend to US$0.25 per share, alongside reporting robust third-quarter earnings with revenue reaching US$1.69 billion and net income of US$118 million, a turnaround from a net loss a year ago. This combination of a higher dividend and improved profitability highlights management's confidence in the company's cash flow and ongoing business momentum. We'll explore how the increased dividend signals sustained earnings...

Bumble Inc. recently reported third-quarter 2025 results showing improved profitability, despite sales falling to US$246.16 million from US$273.61 million in the prior year, and provided fourth-quarter revenue guidance in the US$216 million to US$224 million range. An additional shelf registration for US$127.2 million in Class A Common Stock was filed, connected to an employee stock ownership plan offering, underscoring Bumble's focus on employee incentives. We’ll assess how Bumble’s return...

Wondering if Photronics is underestimated or overpriced right now? You are not alone; many investors are taking a closer look at where true value might lie in this stock. Despite a dip of 2.7% over the past week and a 10.1% slide in the last month, Photronics still boasts an impressive 90.3% return over the last five years, which may hint at strong long-term potential. Recent news around advancements in semiconductor manufacturing processes and broader industry consolidation is sparking...

LegalZoom.com, Inc. recently raised its full-year 2025 revenue guidance to a range of US$748 million to US$752 million and reported third-quarter sales of US$190.16 million, alongside an update on its ongoing share repurchase program. While the company saw robust sales growth, its net income declined year-over-year, highlighting both current operational momentum and ongoing profitability challenges. We'll explore how LegalZoom's upgraded revenue guidance shapes the company's future outlook...

Earlier this month, Viridian Therapeutics announced the successful submission of a Biologics License Application (BLA) to the U.S. FDA for veligrotug, its investigational monoclonal antibody for thyroid eye disease, backed by data from two pivotal phase 3 trials. This milestone marks a significant regulatory step with the potential to offer a new therapy option for patients affected by thyroid eye disease, supported by evidence of efficacy and safety. We’ll explore how the BLA submission,...

Rubrik recently announced a strategic collaboration agreement with Amazon Web Services to enhance cybersecurity and advance secure AI adoption for organizations operating in cloud environments. This partnership introduces Rubrik’s Preemptive Recovery Engine to AWS customers, enabling proactive cyber resilience and unified recovery solutions against sophisticated threats. We'll explore how Rubrik's integration of preemptive data recovery with AWS could strengthen its position in the rapidly...

Adobe (ADBE) shared fresh updates this week, highlighting a substantial jump in online consumer spending along with a growing preference for mobile-first shopping. The company also expanded its Adobe Express partnership into India, unlocking access to millions of new creators. See our latest analysis for Adobe. Adobe shares have been on a choppy ride lately, with enthusiasm around innovation and new international partnerships offset by some persistent concerns. The stock's total shareholder...

Global-E Online (GLBE) has caught investors’ attention recently as its stock shifted direction following a few weeks of ups and downs. The company’s performance raises interesting questions for those weighing its potential after past volatility. See our latest analysis for Global-E Online. After a bumpy ride in the first half of the year, Global-E Online's share price has rebounded with a 15.2% gain over the past 90 days, suggesting some renewed optimism despite a year-to-date share price...

Zenas BioPharma (ZBIO) is in the spotlight after announcing strong Phase 2 results for obexelimab in relapsing multiple sclerosis, the launch of key Phase 3 trials, and a major funding deal with Royalty Pharma. See our latest analysis for Zenas BioPharma. Zenas BioPharma's impressive 90-day share price return of 108.09% and an exceptional year-to-date gain of 288.46% point to surging investor optimism, propelled by breakthrough clinical results and major funding milestones. Short-term...

Banc of California (BANC) shares have edged higher lately, with the stock up about 12% year to date and returning roughly 10% over the past three months. Investors seem to be considering the company’s growth story as markets assess recent performance. See our latest analysis for Banc of California. Banc of California’s latest share price return of nearly 12% this year stands out, with the momentum picking up pace over the past quarter. The total shareholder return over the last twelve months...